Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2021
/
Article
/
Tab 1
/
Research Article
[Retracted] Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer
Table 1
Comparison of general data between the two groups.
General clinical data
Control group (
n
= 58)
Observation group (
n
= 58)
t/χ
2
Age (years old)
50.06 ± 9.59
50.30 ± 9.41
0.136
0.892
Gender
0.558
0.455
Male
30
34
Female indent
28
24
Tumor location
0.666
0.415
Left
43
39
Right
15
19
Pathological grade
1.451
0.229
Moderately or highly differentiated
37
43
Poorly differentiated
21
15
Peritoneal metastasis
0.372
0.542
Yes
5
7
No
53
51